US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sionna Therapeutics

7.18

+0.14001.99%

Post-market: 7.180.00000.00%19:30 EDT

Volume:1.48M

Turnover:10.95M

Market Cap:323.09M

PE:-3.31

High:7.73

Open:7.27

Low:7.15

Close:7.04

52wk High:54.97

52wk Low:4.01

Shares:45.00M

Float Shares:16.73M

Volume Ratio:0.92

T/O Rate:8.86%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1683

EPS(LYR):-1.8835

ROE:-32.34%

ROA:-21.54%

PB:1.22

PE(LYR):-3.81

Loading ...

Overview Company News Filings

Sionna Therapeutics price target raised to $63 from $52 at JonesResearch

Sionna Therapeutics announces annual shareholder meeting

Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG

Sionna Therapeutics completes enrollment in Phase 2a PreciSION CF trial of SION-719

Sionna Therapeutics Inc: Anticipates Data From Precision CF Trial in Summer of 2026.

THOMSON REUTERS

Sionna Therapeutics Completes Enrollment in Precision CF Phase 2a Trial Evaluating Nbd1 Stabilizer, Sion-719, Added to Standard of Care in Participants With Cystic Fibrosis

THOMSON REUTERS

Sionna director Peter A. Thompson disposes of USD 2.5 million common shares

OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $2.5 million

Sionna director Peter A. Thompson disposes of common shares worth $23.2 million

OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $23.1 million

Assessing Sionna Therapeutics (SION) Valuation After Recent Trading And Cystic Fibrosis Pipeline Expectations

Simply Wall St.

Sionna Therapeutics to attend Raymond James Biotech Innovation Symposium investor meetings

Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium

A Look At Sionna Therapeutics (SION) Valuation After A 166% One Year Share Price Gain

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/SION/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":7.18,"timestamp":1789675200000,"preClose":7.04,"halted":0,"volume":1481560,"hourTrading":{"tag":"盘后","latestPrice":7.18,"preClose":7.18,"latestTime":"19:30 EDT","volume":17604,"amount":126570.7935,"timestamp":1789687803511,"change":0,"changeRate":0,"amplitude":0.038997},"delay":0,"changeRate":0.01988636363636359,"floatShares":16725500,"shares":44998073,"eps":-2.16827,"marketStatus":"Not Yet Opened","change":0.14,"latestTime":"09-17 16:00:00 EDT","open":7.27,"high":7.73,"low":7.15,"amount":10948210.298468,"amplitude":0.082386,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.16827,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789718400000},"marketStatusCode":0,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":7.04,"preHourTrading":{"tag":"盘前","latestPrice":7.15,"preClose":7.04,"latestTime":"09:29 EDT","volume":90051,"amount":645174.711948,"timestamp":1789651741016,"change":0.11,"changeRate":0.015625,"amplitude":0.060639},"postHourTrading":{"tag":"盘后","latestPrice":7.18,"preClose":7.18,"latestTime":"19:30 EDT","volume":17604,"amount":126570.7935,"timestamp":1789687803511,"change":0,"changeRate":0,"amplitude":0.038997},"volumeRatio":0.916182,"impliedVol":1.7512,"impliedVolPercentile":0.6484},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":16725500,"roa":"-21.54%","roe":"-32.34%","lyrEps":-1.883481,"volumeRatio":0.916182,"shares":44998073,"dividePrice":0,"high":7.73,"amplitude":0.082386,"preClose":7.04,"low":7.15,"week52Low":4.01,"pbRate":"1.22","week52High":54.97,"institutionHeld":0,"latestPrice":7.18,"eps":-2.16827,"divideRate":0,"volume":1481560,"delay":0,"ttmEps":-2.16827,"open":7.27,"prevYearClose":41.14,"prevWeekClose":7.85,"prevMonthClose":6.03,"prevQuarterClose":43.99,"fiveDayClose":7.62,"twentyDayClose":6.25,"sixtyDayClose":39.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"SION","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.66},{"market":"US","date":"2026-05-12","symbol":"SION","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"pre","actualEps":-0.6},{"market":"US","date":"2026-03-02","symbol":"SION","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-11-05","symbol":"SION","fiscalQuarterEnding":"2025/09","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2025-08-11","symbol":"SION","fiscalQuarterEnding":"2025/06","expectedEps":-0.68,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.41}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.0909,"hold":0.9091,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9091,"analysts":11,"updateTime":1786420800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2026-09-16","current":-3.311396,"percent":0.955224,"low":-28.087165,"twenty":-23.958714,"median":-17.956708,"eighty":-9.745019,"high":-2.089233,"avg":-17.121429,"sd":7.250659,"marketCap":311061305},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940},{"date":"2025-04-25","current":-9.012569,"twenty":-13.535074,"median":-10.607665,"eighty":-7.830921,"marketCap":555967364},{"date":"2025-05-02","current":-9.227154,"twenty":-13.113134,"median":-10.157913,"eighty":-8.049798,"marketCap":569204682},{"date":"2025-05-09","current":-8.991111,"twenty":-13.07005,"median":-9.363058,"eighty":-8.189398,"marketCap":554643632},{"date":"2025-05-16","current":-8.935031,"twenty":-13.050179,"median":-9.227154,"eighty":-8.189398,"marketCap":592598052},{"date":"2025-05-23","current":-8.649163,"twenty":-12.684872,"median":-9.227154,"eighty":-8.258154,"marketCap":573638442},{"date":"2025-05-30","current":-9.380453,"twenty":-12.498397,"median":-9.212848,"eighty":-8.290133,"marketCap":622139770},{"date":"2025-06-06","current":-10.656886,"twenty":-12.42503,"median":-9.227154,"eighty":-8.395596,"marketCap":706796635},{"date":"2025-06-13","current":-11.295102,"twenty":-12.251212,"median":-9.28738,"eighty":-8.459628,"marketCap":749125067},{"date":"2025-06-20","current":-9.792634,"twenty":-12.067794,"median":-9.313972,"eighty":-8.462287,"marketCap":649476883},{"date":"2025-06-27","current":-9.859115,"twenty":-11.920631,"median":-9.377129,"eighty":-8.491142,"marketCap":653886095},{"date":"2025-07-03","current":-14.087299,"twenty":-12.050418,"median":-9.569923,"eighty":-8.540482,"marketCap":934311959},{"date":"2025-07-11","current":-13.921097,"twenty":-12.562594,"median":-9.646376,"eighty":-8.576247,"marketCap":923288929},{"date":"2025-07-18","current":-12.185946,"twenty":-12.955414,"median":-9.792431,"eighty":-8.606288,"marketCap":808208504},{"date":"2025-07-25","current":-12.724441,"twenty":-12.981363,"median":-9.952188,"eighty":-8.61201,"marketCap":843923119},{"date":"2025-08-01","current":-11.142196,"twenty":-12.981363,"median":-10.527086,"eighty":-8.61201,"marketCap":738983880},{"date":"2025-08-08","current":-11.487897,"twenty":-12.719123,"median":-10.607665,"eighty":-8.619441,"marketCap":761911781},{"date":"2025-08-15","current":-12.17004,"twenty":-12.719123,"median":-10.776552,"eighty":-8.650316,"marketCap":922963698},{"date":"2025-08-22","current":-13.817157,"twenty":-12.981363,"median":-10.951574,"eighty":-8.660649,"marketCap":1047879398},{"date":"2025-08-29","current":-14.969557,"twenty":-13.185819,"median":-11.135548,"eighty":-8.685971,"marketCap":1135276247},{"date":"2025-09-05","current":-13.421384,"twenty":-13.261013,"median":-11.264381,"eighty":-8.6957,"marketCap":1017864318},{"date":"2025-09-12","current":-13.849168,"twenty":-13.582045,"median":-11.295102,"eighty":-8.81229,"marketCap":1050307088},{"date":"2025-09-19","current":-13.520327,"twenty":-13.543608,"median":-11.380538,"eighty":-8.928383,"marketCap":1025368088},{"date":"2025-09-26","current":-16.005553,"twenty":-13.817157,"median":-11.448008,"eighty":-8.935031,"marketCap":1213845132},{"date":"2025-10-03","current":-17.053189,"twenty":-13.934393,"median":-11.481249,"eighty":-8.974919,"marketCap":1293296813},{"date":"2025-10-10","current":-16.50027,"twenty":-14.087299,"median":-11.594266,"eighty":-8.991111,"marketCap":1251363982},{"date":"2025-10-17","current":-19.043698,"twenty":-14.329335,"median":-11.773765,"eighty":-9.012569,"marketCap":1444255008},{"date":"2025-10-24","current":-23.047996,"twenty":-14.678547,"median":-11.960372,"eighty":-9.101233,"marketCap":1747936990},{"date":"2025-10-31","current":-22.122584,"twenty":-14.777491,"median":-12.128534,"eighty":-9.127014,"marketCap":1677754672},{"date":"2025-11-07","current":-21.722088,"twenty":-15.059369,"median":-12.17004,"eighty":-9.148473,"marketCap":1535230307},{"date":"2025-11-14","current":-22.656643,"twenty":-15.557397,"median":-12.201274,"eighty":-9.173508,"marketCap":1601280913},{"date":"2025-11-21","current":-24.588899,"twenty":-16.50027,"median":-12.318908,"eighty":-9.207602,"marketCap":1737845004},{"date":"2025-11-28","current":-27.51254,"twenty":-16.690008,"median":-12.434201,"eighty":-9.211799,"marketCap":1944476293},{"date":"2025-12-05","current":-25.813923,"twenty":-17.070649,"median":-12.542534,"eighty":-9.224293,"marketCap":1824424853},{"date":"2025-12-12","current":-26.344347,"twenty":-17.43383,"median":-12.644664,"eighty":-9.227154,"marketCap":1861913035},{"date":"2025-12-19","current":-27.916672,"twenty":-18.615331,"median":-12.828464,"eighty":-9.244321,"marketCap":1973038717},{"date":"2025-12-26","current":-27.799853,"twenty":-20.840976,"median":-13.015231,"eighty":-9.271873,"marketCap":1964782391},{"date":"2026-01-02","current":-25.978102,"twenty":-21.880226,"median":-13.072343,"eighty":-9.298017,"marketCap":1836028338},{"date":"2026-01-09","current":-23.111292,"twenty":-22.280894,"median":-13.196456,"eighty":-9.333606,"marketCap":1633413640},{"date":"2026-01-16","current":-24.532068,"twenty":-22.755262,"median":-13.25865,"eighty":-9.367357,"marketCap":1733828413},{"date":"2026-01-23","current":-26.375919,"twenty":-23.010449,"median":-13.309024,"eighty":-9.375135,"marketCap":1864144474},{"date":"2026-01-30","current":-26.798995,"twenty":-23.217376,"median":-13.467945,"eighty":-9.407045,"marketCap":1894045762},{"date":"2026-02-06","current":-22.258826,"twenty":-24.10394,"median":-13.562826,"eighty":-9.536018,"marketCap":1573164777},{"date":"2026-02-13","current":-23.768006,"twenty":-23.957443,"median":-13.817157,"eighty":-9.627762,"marketCap":1679827580},{"date":"2026-02-20","current":-23.578569,"twenty":-24.004802,"median":-13.914449,"eighty":-9.63308,"marketCap":1666438943},{"date":"2026-02-27","current":-23.99533,"twenty":-24.004802,"median":-13.951438,"eighty":-9.646376,"marketCap":1695893944},{"date":"2026-03-06","current":-20.661282,"twenty":-23.99533,"median":-14.087299,"eighty":-9.713547,"marketCap":1555133402},{"date":"2026-03-13","current":-21.928699,"twenty":-23.824837,"median":-14.227481,"eighty":-9.792228,"marketCap":1650529317},{"date":"2026-03-20","current":-21.217272,"twenty":-23.768006,"median":-14.329335,"eighty":-9.792634,"marketCap":1596981610},{"date":"2026-03-27","current":-22.693932,"twenty":-23.692231,"median":-14.628741,"eighty":-9.859115,"marketCap":1708126851},{"date":"2026-04-02","current":-24.690711,"twenty":-23.779372,"median":-14.699136,"eighty":-9.933573,"marketCap":1858420414},{"date":"2026-04-10","current":-23.249921,"twenty":-23.779372,"median":-14.763927,"eighty":-10.393622,"marketCap":1749975058},{"date":"2026-04-17","current":-27.046193,"twenty":-23.997224,"median":-14.955149,"eighty":-10.519675,"marketCap":2035712822},{"date":"2026-04-24","current":-22.927089,"twenty":-24.052712,"median":-15.059369,"eighty":-10.529177,"marketCap":1725676099},{"date":"2026-05-01","current":-23.210503,"twenty":-24.014274,"median":-15.233234,"eighty":-10.592246,"marketCap":1747008171},{"date":"2026-05-08","current":-25.975372,"twenty":-24.255396,"median":-15.761105,"eighty":-10.607665,"marketCap":1955114312},{"date":"2026-05-15","current":-22.568569,"twenty":-24.314473,"median":-16.442494,"eighty":-10.647042,"marketCap":1931079614},{"date":"2026-05-22","current":-22.030343,"twenty":-24.255396,"median":-16.587573,"eighty":-10.662204,"marketCap":1885026277},{"date":"2026-05-29","current":-22.584399,"twenty":-24.225568,"median":-16.843662,"eighty":-10.799155,"marketCap":1932434124},{"date":"2026-06-05","current":-19.935481,"twenty":-24.091149,"median":-17.056099,"eighty":-10.92148,"marketCap":1705779467},{"date":"2026-06-12","current":-19.022607,"twenty":-24.014274,"median":-17.123032,"eighty":-10.948046,"marketCap":1627669396},{"date":"2026-06-18","current":-19.381425,"twenty":-24.010485,"median":-17.425682,"eighty":-10.97603,"marketCap":1658371620},{"date":"2026-06-26","current":-22.568569,"twenty":-24.001013,"median":-17.729808,"eighty":-11.059188,"marketCap":1931079614},{"date":"2026-07-02","current":-21.972299,"twenty":-23.989729,"median":-17.973475,"eighty":-11.131559,"marketCap":1880059741},{"date":"2026-07-10","current":-23.713619,"twenty":-23.938829,"median":-18.418073,"eighty":-11.16347,"marketCap":2029055830},{"date":"2026-07-17","current":-23.898305,"twenty":-23.898305,"median":-18.702419,"eighty":-11.254892,"marketCap":2044858445},{"date":"2026-07-24","current":-23.249267,"twenty":-23.989729,"median":-18.996224,"eighty":-11.281848,"marketCap":1989323539},{"date":"2026-07-31","current":-24.684537,"twenty":-24.004802,"median":-19.043698,"eighty":-11.288454,"marketCap":2112132437},{"date":"2026-08-07","current":-23.001015,"twenty":-24.109374,"median":-19.37351,"eighty":-11.295102,"marketCap":2239907871},{"date":"2026-08-14","current":-3.036352,"twenty":-24.014274,"median":-19.249507,"eighty":-11.248566,"marketCap":295689089},{"date":"2026-08-21","current":-2.562793,"twenty":-24.014274,"median":-19.009416,"eighty":-10.951574,"marketCap":249572442},{"date":"2026-08-28","current":-2.813501,"twenty":-24.004802,"median":-18.741047,"eighty":-10.656886,"marketCap":273987137},{"date":"2026-09-04","current":-3.13385,"twenty":-23.99533,"median":-18.500988,"eighty":-10.523599,"marketCap":305183693},{"date":"2026-09-11","current":-3.537768,"twenty":-23.972928,"median":-18.163438,"eighty":-9.845819,"marketCap":344518480},{"date":"2026-09-16","current":-3.194205,"twenty":-23.958714,"median":-17.956708,"eighty":-9.745019,"marketCap":311061305}],"updateTime":1789715966282},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630770733","title":"Sionna Therapeutics price target raised to $63 from $52 at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2630770733","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630770733?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:20","pubTimestamp":1777371616,"startTime":"0","endTime":"0","summary":"JonesResearch raised the firm’s price target on Sionna Therapeutics (SION) to $63 from $52 and keeps a Buy rating on the shares after the company c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-price-target-raised-to-63-from-52-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-price-target-raised-to-63-from-52-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630127453","title":"Sionna Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630127453","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630127453?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:05","pubTimestamp":1777320349,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics will hold its 2026 annual stockholder meeting online on June 17, 2026.Shareholders will vote on election of four Class II directors with terms running to 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL86h43S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630316157","title":"Sionna Therapeutics Price Target Maintained With a $58.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2630316157","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630316157?lang=en_us&edition=fundamental","pubTime":"2026-04-28 00:50","pubTimestamp":1777308600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SION/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 27, 2026 12:50 ET (16:50 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630984003","title":"Sionna Therapeutics completes enrollment in Phase 2a PreciSION CF trial of SION-719","url":"https://stock-news.laohu8.com/highlight/detail?id=2630984003","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630984003?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:02","pubTimestamp":1777287730,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics completed enrollment in PreciSION CF, a Phase 2a proof-of-concept trial testing SION-719 added to Trikafta in adults with cystic fibrosis.Results have not been presented; topline data are expected in summer 2026.Study aims to show whether SION-719 can improve CFTR function when used on top of current standard of care, while remaining safe and tolerable.Program positions SION-719 as a first-in-class approach targeting the underlying defect linked to the most common CF-causing mutation, supporting Sionna’s strategy to extend benefits beyond existing modulators.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL74dFTv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR","SION","BK4588","BK4112","LU2210150020.SGD","SG9999014013.SGD","BK4585","IE00B3QW5Z07.USD","LU2095319765.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","SG9999014039.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4139","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630398997","title":"Sionna Therapeutics Inc: Anticipates Data From Precision CF Trial in Summer of 2026.","url":"https://stock-news.laohu8.com/highlight/detail?id=2630398997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630398997?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUAQD018:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630139894","title":"Sionna Therapeutics Completes Enrollment in Precision CF Phase 2a Trial Evaluating Nbd1 Stabilizer, Sion-719, Added to Standard of Care in Participants With Cystic Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2630139894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630139894?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:00","pubTimestamp":1777287600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUAQD018:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629062322","title":"Sionna director Peter A. Thompson disposes of USD 2.5 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2629062322","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629062322?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:43","pubTimestamp":1776818586,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics director Peter A. Thompson reported sales of common stock on April 17-18.Transaction totaled 55,345 shares at prices of USD 44.52 to USD 44.68.Beneficial ownership following transactions was 2,964,774 shares held indirectly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL8TVmL0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629314062","title":"OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $2.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629314062","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629314062?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:40","pubTimestamp":1776818454,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors LLC, director, sold 55,345 shares of Sionna Therapeutics common stock on April 17-18.Sales were reported at prices of USD 44.68, USD 44.52.Indirect beneficial ownership following transactions was 2,964,774 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL6FbmBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $2.5 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628247968","title":"Sionna director Peter A. Thompson disposes of common shares worth $23.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2628247968","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628247968?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:15","pubTimestamp":1776381346,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics director Peter A. Thompson reported sales of 510,583 shares of common stock on April 14-16.Transactions were priced at USD 44.51-45.34 per share.Indirect beneficial ownership fell to 3,020,119 shares following the reported sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL4prYcG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628324755","title":"OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $23.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2628324755","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628324755?lang=en_us&edition=fundamental","pubTime":"2026-04-17 07:04","pubTimestamp":1776380657,"startTime":"0","endTime":"0","summary":"OrbiMed Advisors, company director, reported sale of 510,583 Sionna Therapeutics common shares on April 14-16.Sales priced between $44.51 and $45.34 per share.Indirect beneficial ownership fell to 3,020,119 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL7CpQlK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"OrbiMed Advisors reports Sionna Therapeutics common stock disposal worth $23.1 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626198437","title":"Assessing Sionna Therapeutics (SION) Valuation After Recent Trading And Cystic Fibrosis Pipeline Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2626198437","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626198437?lang=en_us&edition=fundamental","pubTime":"2026-04-10 15:22","pubTimestamp":1775805722,"startTime":"0","endTime":"0","summary":"What recent performance says about Sionna Therapeutics\nSionna Therapeutics (SION) has drawn fresh attention after recent trading, with the stock closing at $38.89. Over the past month, the share price return sits near 2%, while the past 3 months are slightly negative.\nSee our latest analysis for Sionna Therapeutics.\nThat 5.25% 1 day share price return stands in contrast to a slightly negative year to date share price return of 0.82%. The 1 year total shareholder return of about 4x hints at...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/assessing-sionna-therapeutics-sion-valuation-after-recent-tr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/assessing-sionna-therapeutics-sion-valuation-after-recent-tr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932965","title":"Sionna Therapeutics to attend Raymond James Biotech Innovation Symposium investor meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932965?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:06","pubTimestamp":1775560012,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics management to hold one-on-one investor meetings at Raymond James 2026 Biotech Innovation Symposium on April 14, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sionna Therapeutics Inc. published the original content used to generate this news brief on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL8BbhCc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SION","IE00B64PRP62.GBP","RJF","BK4127","BK4139","LU1804176565.USD","LU2265009873.SGD","LU0971096721.USD","LU1363072403.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625471932","title":"Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2625471932","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625471932?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559600,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., April  07, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3268961/0/en/Sionna-Therapeutics-to-Participate-in-the-Raymond-James-2026-Biotech-Innovation-Symposium.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF","IE00B3QW5Z07.USD","LU1804176565.USD","BK4093","XBI","SION","BK4588","BK4581","LU0971096721.USD","LU1363072403.SGD","BK4139","BK4127","BK4585","RJF","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621718054","title":"A Look At Sionna Therapeutics (SION) Valuation After A 166% One Year Share Price Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2621718054","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621718054?lang=en_us&edition=fundamental","pubTime":"2026-03-22 11:09","pubTimestamp":1774148958,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics (SION) is back in focus for investors after recent trading left the shares with a return of about 166% over the past year, contrasting with weaker near term moves.\nSee our latest analysis for Sionna Therapeutics.\nThe share price is currently US$36.39, and short term share price returns over 1 and 3 months have been weak, yet the 1 year total shareholder return of about 166% points to strong earlier momentum that has recently cooled.\nIf you are looking beyond a single...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/a-look-at-sionna-therapeutics-sion-valuation-after-a-166-one","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sion/sionna-therapeutics/news/a-look-at-sionna-therapeutics-sion-valuation-after-a-166-one","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","SION"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":114,"code":"91000000","status":"200"}]}}